Evidence map›Paper›PMID 29124870›Full record

ArticleBJU international2018

Defining a glycated haemoglobin (HbA1c) level that predicts increased risk of penile implant infection.

Mohamad Habous, Raanan Tal, Alaa Tealab, Tarek Soliman, Mohammed Nassar, Zenhom Mekawi, Saad Mahmoud, Osama Abdelwahab, Mohamed Elkhouly, Hatem Kamr and 4 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in BJU international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Update on penile prosthesis.Asian journal of andrology · 2026
    Review
  9. Practice patterns of Canadian penile prosthesis implanters A survey-based analysis.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  10. Risky business: penile prosthesis in high-risk patients.Translational andrology and urology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Mohamad HabousUrology and Andrology Department, Elaj Medical Centers, Jeddah, Saudi Arabia.ORCID 0000-0002-4867-6646
Raanan TalSexual and Reproductive Medicine Program, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alaa TealabUrology, Zagazig University, Benha, Egypt.
Tarek SolimanUrology, Benha University, Benha, Egypt.
Mohammed NassarUrology and Andrology Department, Elaj Medical Centers, Jeddah, Saudi Arabia.
Zenhom MekawiUrology and Andrology Department, Elaj Medical Centers, Jeddah, Saudi Arabia.
Saad MahmoudUrology and Andrology Department, Elaj Medical Centers, Jeddah, Saudi Arabia.
Osama AbdelwahabUrology, Benha University, Benha, Egypt.
Mohamed ElkhoulyUrology and Andrology Department, Elaj Medical Centers, Jeddah, Saudi Arabia.
Hatem KamrUrology and Andrology Department, Elaj Medical Centers, Jeddah, Saudi Arabia.
Abdallah RemeahUrology and Andrology Department, Elaj Medical Centers, Jeddah, Saudi Arabia.
Saleh BinsalehDivision of Urology, Department of Surgery, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
David RalphSt Peters Andrology Centre and The Institute of Urology, University College London Hospital (UCLH), London, UK.
John MulhallSexual and Reproductive Medicine Program, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Benha University · EGMemorial Sloan Kettering Cancer Center · USKing Saud University · SAUniversity College Hospital · GBZagazig University · EG

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectivesTo re-evaluate the role of diabetes mellitus (DM) as a risk factor for penile implant infection by exploring the association between glycated haemoglobin (HbA1c) levels and penile implant infection rates and to define a threshold value that predicts implant infection. PATIENTS AND

methodsWe conducted a multicentre prospective study including all patients undergoing penile implant surgery between 2009 and 2015. Preoperative, perioperative and postoperative management were identical for the entire cohort. Univariate analysis was performed to define predictors of implant infection. The HbA1c levels were analysed as continuous variables and sequential analysis was conducted using 0.5% increments to define a threshold level predicting implant infection. Multivariable analysis was performed with the following factors entered in the model: DM, HbA1C level, patient age, implant type, number of vascular risk factors (VRFs), presence of Peyronie's disease (PD), body mass index (BMI), and surgeon volume. A receiver operating characteristic (ROC) curve was generated to define the optimal HbA1C threshold for infection prediction.

resultsIn all, 902 implant procedures were performed over the study period. The mean patient age was 56.6 years. The mean HbA1c level was 8.0%, with 81% of men having a HbA1c level of >6%. In all, 685 (76%) implants were malleable and 217 (24%) were inflatable devices; 302 (33.5%) patients also had a diagnosis of PD. The overall infection rate was 8.9% (80/902). Patients who had implant infection had significantly higher mean HbA1c levels, 9.5% vs 7.8% (P < 0.001). Grouping the cases by HbA1c level, we found infection rates were: 1.3% with HbA1c level of <6.5%, 1.5% for 6.5-7.5%, 6.5% for 7.6-8.5%, 14.7% for 8.6-9.5%, 22.4% for >9.5% (P < 0.001). Patient age, implant type, and number of VRFs were not predictive. Predictors defined on multivariable analysis were: PD, high BMI, and high HbA1c level, whilst a high-volume surgeon had a protective effect and was associated with a reduced infection risk. Using ROC analysis, we determined that a HbA1c threshold level of 8.5% predicted infection with a sensitivity of 80% and a specificity of 65%.

conclusionUncontrolled DM is associated with increased risk of infection after penile implant surgery. The risk is directly related to the HbA1c level. A threshold HbA1c level of 8.5% is suggested for clinical use to identify patients at increased infection risk.

Indexed as

AdultAgedAged, 80 and overBody Mass IndexDiabetes ComplicationsGlycated HemoglobinHumansMaleMiddle AgedPenile IndurationPenile ProsthesisPredictive Value of TestsProspective StudiesProsthesis-Related InfectionsRisk FactorsROC CurveGlycated Hemoglobinhemoglobin A1c protein, humandiabetes mellitusHbA1cinfectionpenile implantpredictors

Identifiers

PMID29124870
PMCPMC7478354
OpenAlexW2767811479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.